Nursing Genomics. Practice Implications Every Nurse Should Know.

Nursing Clinics of North America

Volumn 48, Issue 4, 2013, Pages 499-522

  Umberger, Reba ^a   Holston, Ezra C ^a   Hutson, Sadie P ^a   Pierce, Margaret ^a  

^a UNIVERSITY OF TENNESSEE   (United States)

Author keywords

Ethics; Genetics; Genomics; Nursing education; Nursing practice; Technology

Indexed keywords

CLINICAL COMPETENCE; CURRICULUM; ETHICS; GENETICS; GENOMICS; HUMAN; MEDICAL GENETICS; NURSE ATTITUDE; NURSING CARE; NURSING EDUCATION; NURSING PRACTICE; NURSING PROCESS; ORGANIZATION AND MANAGEMENT; REVIEW; TECHNOLOGY;

ETHICS; GENETICS; GENOMICS; NURSING EDUCATION; NURSING PRACTICE; TECHNOLOGY;

CLINICAL COMPETENCE; CURRICULUM; EDUCATION, NURSING; GENETICS, MEDICAL; GENOMICS; HUMANS; NURSE'S PRACTICE PATTERNS; NURSE'S ROLE; NURSING CARE; NURSING PROCESS;

EID: 84888320397     PISSN: 00296465     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cnur.2013.08.006     Document Type: Review

References (134)

1. Lorentz C.P., Wieben E.D., Tefferi A., et al. Primer on medical genomics part I: history of genetics and sequencing of the human genome. Mayo Clin Proc 2002, 77(8):773-782.
2. Mikail C.N. Public health genomics: the essentials 2008, Jossey-Bass, San Francisco (CA).
3. Beery T., Workman M. Genetics and genomics in nursing and health care 2012, FA Davis, Philadelphia.
4. Nickla H., Klung W.S., Cummings M.R. Essentials of genetics student handbook & solutions manual 2004, Pearson Prentice Hall, Upper Saddle River (NJ). 5th edition.
5. Hartl D.L. Essential genetics: a genomics perspective 2012, Jones and Barlett, Sudbury (MA).
6. Hartl D.L., Jones E.W. Genetics: analysis of genes and genomes 2005, Jones and Barlett, Sudbury (MA). 6th edition.
7. McPhee S.J., Hammer G.D. Pathophysiology of disease: an introduction to clinical medicine 2010, McGraw Hill, New York.
8. Tobias E.S., Conner M., Ferguson-Smith M. Essential medical genetics 2011, Wiley Blackwell, Hoboken (NJ). 6th edition.
9. Barsh G. Genetic disease. Pathophysiology of disease: an introduction to clinical medicine 2010, 2-29. McGraw Hill, New York. S.J. McPhee, G.D. Hammer (Eds.).
10. Guttmacher A.E., Collins F.S., Carmona R.H. The family history-more important than ever. NEngl J Med 2004, 351(22):2333-2336.
11. Anderson C.D., Biffi A., Rost N.S., et al. Chromosome 9p21 in ischemic stroke: population structure and meta-analysis. Stroke 2010, 41(6):1123-1131.
12. Lemmens R., Buysschaert I., Geelen V., et al. The association of the 4q25 susceptibility variant for atrial fibrillation with stroke is limited to stroke of cardioembolic etiology. Stroke 2010, 41(9):1850-1857.
13. Gudbjartsson D.F., Holm H., Gretarsdottir S., et al. Asequence variant in ZFHX3 on 16q22 associates with atrial fibrillation and ischemic stroke. Nat Genet 2009, 41(8):876-878.
14. Froguel P., Vaxillaire M., Sun F., et al. Close linkage of glucokinase locus on chromosome 7p to early-onset non-insulin-dependent diabetes mellitus. Nature 1992, 356(6365):162-164.
15. Garay-Sevilla M.E., Nava L.E., Malacara J.M., et al. Advanced glycosylation end products (AGEs), insulin-like growth factor-1 (IGF-1) and IGF-binding protein-3 (IGFBP-3) in patients with type 2 diabetes mellitus. Diabetes Metab Res Rev 2000, 16(2):106-113.
16. Laakso M., Malkki M., Kekalainen P., et al. Glucokinase gene variants in subjects with late-onset NIDDM and impaired glucose tolerance. Diabetes Care 1995, 18(3):398-400.
17. Vozarova B., Fernandez-Real J.M., Knowler W.C., et al. The interleukin-6 (-174) G/C promoter polymorphism is associated with type-2 diabetes mellitus in Native Americans and Caucasians. Hum Genet 2003, 112(4):409-413.
18. Thomas N.S., Holgate S.T. Candidate locus approach for studying the genetics of asthma and atopy. Monaldi Arch Chest Dis 1997, 52(3):296-302.
19. Elkins J.S., Douglas V.C., Johnston S.C. Alzheimer disease risk and genetic variation in ACE: a meta-analysis. Neurology 2004, 62(3):363-368.
20. Skeehan K., Heaney C., Cook-Deegan R. Impact of gene patents and licensing practices on access to genetic testing for Alzheimer disease. Genet Med 2010, 12(Suppl 4):S71-S82.
21. Vargas-Alarcon G., Zamora J., Sanchez-Garcia S., et al. Angiotensin-I-converting enzyme (ACE) insertion/deletion polymorphism in Mexican patients with coronary artery disease. Association with the disease but not with lipid levels. Exp Mol Pathol 2006, 81(2):131-135.
22. Bouzekri N., Zhu X., Jiang Y., et al. Angiotensin I-converting enzyme polymorphisms, ACE level and blood pressure among Nigerians, Jamaicans and African-Americans. Eur J Hum Genet 2004, 12(6):460-468.
23. Uhm W.S., Lee H.S., Chung Y.H., et al. Angiotensin-converting enzyme gene polymorphism and vascular manifestations in Korean patients with SLE. Lupus 2002, 11(4):227-233.
24. Tadokoro K., Akutsu Y., Tanaka K., et al. Comparative quantitative analysis of 14 types of human papillomavirus by real-time polymerase chain reaction monitoring Invader reaction (Q-Invader assay). Diagn Microbiol Infect Dis 2010, 66(1):58-64.
25. Burd E.M. Human papillomavirus and cervical cancer. Clin Microbiol Rev 2003, 16(1):1-17.
26. Ward T.J., Ducey T.F., Usgaard T., et al. Multilocus genotyping assays for single nucleotide polymorphism-based subtyping of Listeria monocytogenes isolates. Appl Environ Microbiol 2008, 74(24):7629-7642.
27. Rasko D.A., Worsham P.L., Abshire T.G., et al. Bacillus anthracis comparative genome analysis in support of the Amerithrax investigation. Proc Natl Acad Sci USA 2011, 108(12):5027-5032.
28. Taboada E.N., Ross S.L., Mutschall S.K., et al. Development and validation of a comparative genomic fingerprinting method for high-resolution genotyping of Campylobacter jejuni. JClin Microbiol 2012, 50(3):788-797.
29. Gleen K., Du Z.Q., Eisenmann J.C., et al. An alternative method for genotyping of the ACE I/D polymorphism. Mol Biol Rep 2009, 36:1305-1310.
30. Bhatnagar P., Gupta S., Guleria R., et al. beta2-Adrenergic receptor polymorphisms and asthma in the North Indian population. Pharmacogenomics 2005, 6(7):713-719.
31. Leak T.S., Langefeld C.D., Keene K.L., et al. Chromosome 7p linkage and association study for diabetes related traits and type 2 diabetes in an African-American population enriched for nephropathy. BMC Med Genet 2010, 11:22.
32. Simon-Sanchez J., Kilarski L.L., Nalls M.A., et al. Cooperative genome-wide analysis shows increased homozygosity in early onset Parkinson's disease. PLoS One 2012, 7(3):e28787.
33. McBride M.W., Graham D., Delles C., et al. Functional genomics in hypertension. Curr Opin Nephrol Hypertens 2006, 15(2):145-151.
34. Murabito J.M., White C.C., Kavousi M., et al. Association between chromosome 9p21 variants and the ankle-brachial index identified by a meta-analysis of 21 genome-wide association studies. Circ Cardiovasc Genet 2012, 5(1):100-112.
35. Berthier-Schaad Y., Kao W.H., Coresh J., et al. Reliability of high-throughput genotyping of whole genome amplified DNA in SNP genotyping studies. Electrophoresis 2007, 28(16):2812-2817.
36. Macgregor S., Zhao Z.Z., Henders A., et al. Highly cost-efficient genome-wide association studies using DNA pools and dense SNP arrays. Nucleic Acids Res 2008, 36(6):e35.
37. Wiltshire S., de Bakker P.I., Daly M.J. The value of gene-based selection of tag SNPs in genome-wide association studies. Eur J Hum Genet 2006, 14(11):1209-1214.
38. Sigurdsson S., Hedman M., Sistonen P., et al. Amicroarray system for genotyping 150 single nucleotide polymorphisms in the coding region of human mitochondrial DNA. Genomics 2006, 87(4):534-542.
39. Meschia J.F. Ischaemic stroke: one or several complex genetic disorders?. Lancet Neurol 2003, 2(8):459.
40. Steer S., Abkevich V., Gutin A., et al. Genomic DNA pooling for whole-genome association scans in complex disease: empirical demonstration of efficacy in rheumatoid arthritis. Genes Immun 2007, 8(1):57-68.
41. Bentley G., Higuchi R., Hoglund B., et al. High-resolution, high-throughput HLA genotyping by next-generation sequencing. Tissue Antigens 2009, 74(5):393-403.
42. Schymick J.C., Scholz S.W., Fung H.C., et al. Genome-wide genotyping in amyotrophic lateral sclerosis and neurologically normal controls: first stage analysis and public release of data. Lancet Neurol 2007, 6(4):322-328.
43. Piedmont and Valle d'Aosta Register for Amyotrophic Lateral Sclerosis (PARALS) Incidence of ALS in Italy: evidence for a uniform frequency in Western countries. Neurology 2001, 56(2):239-244.
44. Wilkening S., Chen B., Bermejo J.L., et al. Is there still a need for candidate gene approaches in the era of genome-wide association studies?. Genomics 2009, 93(5):415-419.
45. Chanda P., Yuhki N., Li M., et al. Comprehensive evaluation of imputation performance in African Americans. JHum Genet 2012, 57(7):411-421.
46. Levy H.L. Newborn screening conditions: what we know, what we do not know, and how we will know it. Genet Med 2010, 12(Suppl 12):S213-S214.
47. Deluca J., Zanni K.L., Bonhomme N., et al. Implications of newborn screening for nurses. JNurs Scholarsh 2013, 45(1):25-33.
48. Thapar A., O'Donovan M., Owen M.J. The genetics of attention deficit hyperactivity disorder. Hum Mol Genet 2005, 14(Spec No 2):R275-R282.
49. Lionel A.C., Crosbie J., Barbosa N., et al. Rare copy number variation discovery and cross-disorder comparisons identify risk genes for ADHD. Sci Transl Med 2011, 3(95):95ra75.
50. Cannon T.D., Kaprio J., Lonnqvist J., et al. The genetic epidemiology of schizophrenia in a Finnish twin cohort. A population-based modeling study. Arch Gen Psychiatry 1998, 55(1):67-74.
51. Aberg K., Saetre P., Lindholm E., et al. Human QKI, a new candidate gene for schizophrenia involved in myelination. Am J Med Genet B Neuropsychiatr Genet 2006, 141B(1):84-90.
52. Chandrasekharan S., Heaney C., James T., et al. Impact of gene patents and licensing practices on access to genetic testing for cystic fibrosis. Genet Med 2010, 12(Suppl 4):S194-S211.
53. Colaianni A., Chandrasekharan S., Cook-Deegan R. Impact of gene patents and licensing practices on access to genetic testing and carrier screening for Tay-Sachs and Canavan disease. Genet Med 2010, 12(Suppl 4):S5-S14.
54. Chandrasekharan S., Pitlick E., Heaney C., et al. Impact of gene patents and licensing practices on access to genetic testing for hereditary hemochromatosis. Genet Med 2010, 12(4 Suppl):S155-S170.
55. Kang Y., Dong X., Zhou Q., et al. Identification of novel candidate maternal serum protein markers for Down syndrome by integrated proteomic and bioinformatic analysis. Prenat Diagn 2012, 32(3):284-292.
56. Papageorgiou E.A., Karagrigoriou A., Tsaliki E., et al. Fetal-specific DNA methylation ratio permits noninvasive prenatal diagnosis of trisomy 21. Nat Med 2011, 17(4):510-513.
57. Ogilvie V., Passmore M., Hyndman L., et al. Differential global gene expression in cystic fibrosis nasal and bronchial epithelium. Genomics 2011, 98(5):327-336.
58. Pyeritz R.E. Evaluation of the adolescent or adult with some features of Marfan syndrome. Genet Med 2012, 14(1):171-177.
59. Vylet'al P., Kublova M., Kalbacova M., et al. Alterations of uromodulin biology: a common denominator of the genetically heterogeneous FJHN/MCKD syndrome. Kidney Int 2006, 70(6):1155-1169.
60. Srivatsan A., Han Y., Peng J., et al. High-precision, whole-genome sequencing of laboratory strains facilitates genetic studies. PLoS Genet 2008, 4(8):e1000139.
61. Diskin S.J., Li M., Hou C., et al. Adjustment of genomic waves in signal intensities from whole-genome SNP genotyping platforms. Nucleic Acids Res 2008, 36(19):e126.
62. Peiffer D.A., Le J.M., Steemers F.J., et al. High-resolution genomic profiling of chromosomal aberrations using Infinium whole-genome genotyping. Genome Res 2006, 16(9):1136-1148.
63. Xing J., Watkins W.S., Zhang Y., et al. High fidelity of whole-genome amplified DNA on high-density single nucleotide polymorphism arrays. Genomics 2008, 92(6):452-456.
64. Xing J., Watkins W.S., Shlien A., et al. Toward a more uniform sampling of human genetic diversity: a survey of worldwide populations by high-density genotyping. Genomics 2010, 96(4):199-210.
65. Anwar M.A., Shalhoub J., Lim C.S., et al. The effect of pressure-induced mechanical stretch on vascular wall differential gene expression. JVasc Res 2012, 49(6):463-478.
66. McDermott U., Downing J.R., Stratton M.R. Genomics and the continuum of cancercare. N Engl J Med 2011, 364(4):340-350.
67. Cancer Genome Atlas Network Comprehensive molecular portraits of human breast tumors. Nature 2012, 490(7418):61-70.
68. Ornish D., Magbanua M.J., Weidner G., et al. Changes in prostate gene expression in men undergoing an intensive nutrition and lifestyle intervention. Proc Natl Acad Sci USA 2008, 105(24):8369-8374.
69. Kaput J., Rodriguez R.L. Nutritional genomics: the next frontier in the postgenomic era. Physiol Genomics 2004, 16(2):166-177.
70. Campbell K.L., Foster-Schubert K.E., Makar K.W., et al. Gene expression changes in adipose tissue with diet- and/or exercise-induced weight loss. Cancer Prev Res (Phila) 2013, 6(3):217-231.
71. Morozumi T., Kubota T., Sugita N., et al. Alterations of gene expression in human neutrophils induced by smoking cessation. JClin Periodontol 2004, 31(12):1110-1116.
72. Zhang X., Lenburg M.E., Spira A. Comparison of nasal epithelial smoking-induced gene expression on Affymetrix Exon 1.0 and Gene 1.0 ST arrays. ScientificWorldJournal 2013, 2013:951416.
73. Shiue H.S., Lee Y.S., Tsai C.N., et al. Gene expression profile of patients with phadiatop-positive and -negative allergic rhinitis treated with acupuncture. JAltern Complement Med 2010, 16(1):59-68.
74. Rossi E.L. Psychosocial genomics: gene expression, neurogenesis, and human experience in mind-body medicine. Adv Mind Body Med 2002, 18(2):22-30.
75. Conley Y.P., Biesecker L.G., Gonsalves S., et al. Current and emerging technology approaches in genomics. JNurs Scholarsh 2013, 45(1):5-14.
76. Mazzio E.A., Soliman K.F. Basic concepts of epigenetics: impact of environmental signals on gene expression. Epigenetics 2012, 7(2):119-130.
77. Talens R.P., Christensen K., Putter H., et al. Epigenetic variation during the adult lifespan: cross-sectional and longitudinal data on monozygotic twin pairs. Aging Cell 2012, 11(4):694-703.
78. Garcia-Gimenez J.L., Sanchis-Gomar F., Lippi G., et al. Epigenetic biomarkers: a new perspective in laboratory diagnostics. Clin Chim Acta 2012, 413(19-20):1576-1582.
79. Singh H. Teeing up transcription on CpG islands. Cell 2009, 138(1):14-16.
80. Sandoval J., Heyn H., Moran S., et al. Validation of a DNA methylation microarray for 450,000 CpG sites in the human genome. Epigenetics 2011, 6(6):692-702.
81. Dawson M.A., Kouzarides T., Huntly B.J. Targeting epigenetic readers in cancer. NEngl J Med 2012, 367(7):647-657.
82. Hardison R.C. Genome-wide epigenetic data facilitate understanding of disease susceptibility association studies. JBiol Chem 2012, 287(37):30932-30940.
83. Tollefsbos T. Epigenetics in human disease 2012, Elsevier, Oxford (United Kingdom).
84. Jakovcevski M., Akbarian S. Epigenetic mechanisms in neurological disease. Nat Med 2012, 18(8):1194-1204.
85. Vachani A., Moon E., Wakeam E., et al. Gene therapy for lung neoplasms. Clin Chest Med 2011, 32(4):865-885.
86. Evans C.H., Ghivizzani S.C., Robbins P.D. Arthritis gene therapy's first death. Arthritis Res Ther 2008, 10(3):110.
87. Kamimura K., Suda T., Zhang G., et al. Advances in gene delivery systems. Pharmaceut Med 2011, 25(5):293-306.
88. Li C., Li L., Keates A.C. Targeting cancer gene therapy with magnetic nanoparticles. Oncotarget 2012, 3(4):365-370.
89. Bowers W.J., Breakefield X.O., Sena-Esteves M. Genetic therapy for the nervous system. Hum Mol Genet 2011, 20(R1):R28-R41.
90. Goyenvalle A., Seto J.T., Davies K.E., et al. Therapeutic approaches to muscular dystrophy. Hum Mol Genet 2011, 20(R1):R69-R78.
91. Rivat C., Santilli G., Gaspar H.B., et al. Gene therapy for primary immunodeficiencies. Hum Gene Ther 2012, 23(7):668-675.
92. Sinn P.L., Anthony R.M., McCray P.B. Genetic therapies for cystic fibrosis lung disease. Hum Mol Genet 2011, 20(R1):R79-R86.
93. Whalen J. Gene-therapy approval marks major milestone. Wall St J 2012, Available at:, Accessed March 22, 2013. http://online.wsj.com/article/SB10001424052970203707604578095091940871524.html.
94. Day J.J., Sweatt J.D. Epigenetic treatments for cognitive impairments. Neuropsychopharmacology 2012, 37(1):247-260.
95. Vessell E.S. Drug therapy, pharmacogenetics. NEngl J Med 1972, 287(18):904-909.
96. Scott S.A. Personalizing medicine with clinical pharmacogenetics. Genet Med 2011, 13(12):987-995.
97. Eriksson N., Wadelius M. Prediction of warfarin dose: why, when and how?. Pharmacogenomics 2012, 13(4):429-440.
98. Carlquist J.F., Anderson J.L. Using pharmacogenetics in real time to guide warfarin initiation: a clinician update. Circulation 2011, 124(23):2554-2559.
99. Auffray C., Caulfield T., Khoury M.J., et al. 2012 highlights in translational 'omics. Genome Med 2013, 5(1):10.
100. Martin M.A., Klein T.E., Dong B.J., et al. Clinical pharmacogenetics implementation consortium guidelines for HLA-B genotype and abacavir dosing. Clin Pharmacol Ther 2012, 91(4):734-738.
101. Hicks J.K., Crews K.R., Hoffman J.M., et al. Aclinician-driven automated system for integration of pharmacogenetic interpretations into an electronic medical record. Clin Pharmacol Ther 2012, 92(5):563-566.
102. Kasarskis A., Yang X., Schadt E. Integrative genomics strategies to elucidate the complexity of drug response. Pharmacogenomics 2011, 12(12):1695-1715.
103. Bunnik E.M., Janssens A.C., Schermer M.H. Informed consent in direct-to-consumer personal genome testing: the outline of a model between specific and generic consent. Bioethics 2012, [Epub ahead of print].
104. Janssens A.C., Gwinn M., Bradley L.A., et al. Acritical appraisal of the scientific basis of commercial genomic profiles used to assess health risks and personalize health interventions. Am J Hum Genet 2008, 82(3):593-599.
105. Myers M.F. Health care providers and direct-to-consumer access and advertising of genetic testing in the United States. Genome Med 2011, 3(12):81.
106. European Academies Science Advisory Council. Direct-to-consumer genetic testing for health-related purposes in the European Union. 2012. Available at: Accessed January 12, 2013. http://www.easac.eu/home/reports-and-statements/detail-view/article/direct-to-co.html.
107. Anderson-Minshall D. Can Your Genes Explain Sexual Orientation?. The Advocate 2012, 2. Available at:, Accessed March 22, 2013. http://www.advocate.com/print-issue/current-issue/2012/10/30/can-your-genes-explain-sexual-orientation.
108. Calzone K.A., Cashion A., Feetham S., et al. Nurses transforming health care using genetics and genomics. Nurs Outlook 2010, 58(1):26-35.
109. Daack-Hirsch S., Dieter C., Quinn Griffin M.T. Integrating genomics into undergraduate nursing education. JNurs Scholarsh 2011, 43(3):223-230.
110. Kirk M., Calzone K., Arimori N., et al. Genetics-genomics competencies and nursing regulation. JNurs Scholarsh 2011, 43(2):107-116.
111. Williams J.K., Prows C.A., Conley Y.P., et al. Strategies to prepare faculty to integrate genomics into nursing education programs. JNurs Scholarsh 2011, 43(3):231-238.
112. Tonkin E., Calzone K., Jenkins J., et al. Genomic education resources for nursing faculty. JNurs Scholarsh 2011, 43(4):330-340.
113. Jenkins J., Bednash G., Malone B. Bridging the gap between genomics discoveries and clinical care: nurse faculty are key. JNurs Scholarsh 2011, 43(1):1-2.
114. Calzone K.A., Jenkins J., Yates J., et al. Survey of nursing integration of genomics into nursing practice. JNurs Scholarsh 2012, 44(4):428-436.
115. Consensus Panel on Genetic/Genomic Nurse Competencies Essentials of genetic and genomic nursing: competencies curricula guidelines, and outcome indicators 2009, American Nurses Association, Silver Spring (MD). 2nd edition.
116. Greco K., Tinley S., Seibert D. Essential genetic and genomic competencies for nurses with graduate degrees 2012, American Nurses Association and International Society of Nurses in Genetics, Silver Spring (MD). 2nd edition.
117. National Coalition for Health Professional Education in Genetics. Core competencies in genetics for health professionals. 3rd edition. 2007. Available at: Accessed February 1, 2013. http://www.nchpeg.org/index.php?option=com_content%26view=article%26id=237%26Itemid=84.
118. Calzone K.A., Jenkins J. Genomics education in nursing in the United States. Annu Rev Nurs Res 2011, 29:151-172.
119. Jenkins J.F., Calzone K.A. Are nursing faculty ready to integrate genomic content into curricula?. Nurse Educ 2012, 37(1):25-29.
120. Thompson H.J., Brooks M.V. Genetics and genomics in nursing: evaluating Essentials implementation. Nurse Educ Today 2011, 31(6):623-627.
121. Garcia S., Greco K., Loescher L. Teaching strategies to incorporate genomics education into academic nursing curricula. JNurs Educ 2011, 50(11):612-619.
122. Shuster M. Can genetics and genomics nursing competencies be successfully taught in a prenursing microbiology course?. CBE Life Sci Educ 2011, 10(2):216-221.
123. Institute of Medicine Integrating large-scale genomic information into clinical practice: workshop summary 2011, The National Academies Press, Washington, DC.
124. Pestka E.L., Meiers S.J., Shah L.L., et al. Nurses' perceived benefits, barriers, and educational recommendations for using family pedigrees in clinical practice. JContin Educ Nurs 2012, 43(11):509-517.
125. Richmond E.S., Dunn D. Biomarkers: an overview for oncology nurses. Semin Oncol Nurs 2012, 28(2):87-92.
126. Beery T.A., Smith C.R. Genetics/genomics advances to influence care for patients with chronic disease. Rehabil Nurs 2011, 36(2):54-59. 88.
127. Saunders M. The human genome project: an historical perspective for social workers. Soc Work Public Health 2011, 26(4):336-348.
128. Roberts L., Davenport R.J., Pennisi E., et al. Ahistory of the Human Genome Project. Science 2001, 291(5507):1195.
129. National Human Genome Research Institute. Genetic Information Nondiscrimination Act (GINA) of 2008. 2012. Available at: Accessed February 9, 2013. http://www.genome.gov/24519851.
130. Badzek L., Henaghan M., Turner M., et al. Ethical, legal, and social issues in the translation of genomics into health care. JNurs Scholarsh 2013, 45(1):15-24.
131. McGuire A.L., Majumder M.A. Two cheers for GINA?. Genome Med 2009, 1(1):6.
132. Henderson G.E., Juengst E.T., King N.M., et al. What research ethics should learn from genomics and society research: lessons from the ELSI Congress of 2011. JLaw Med Ethics 2012, 40(4):1008-1024.
133. Patient Protection and Affordable Care Act (2010). H.R. 3590. U.S 111th Congress. Available at: Accessed September 27, 2013. http://www.gpo.gov/fdsys/pkg/PLAW-111publ148/pdf/PLAW-111publ148.pdf.
134. Offit K. Personalized medicine: new genomics, old lessons. Hum Genet 2011, 130(1):3-14.